Results 91 to 100 of about 10,335 (173)
Pentraxin3 in chronic thromboembolic pulmonary hypertension: a new biomarker for screening from remitted pulmonary thromboembolism.
PLoS ONE, 2014 BackgroundPentraxin3 (PTX3) is a protein, which has multifaceted effects on innate immunity, angiogenesis, and vascular remodeling then could be a disease marker of acute myocardial infarction, heart failure, vasculitis.Akira Naito, Nobuhiro Tanabe, Takayuki Jujo, Ayako Shigeta, Toshihiko Sugiura, Seiichiro Sakao, Keiichi Ishida, Koichiro Tatsumi +7 moredoaj +1 more sourceChronic thromboembolic pulmonary hypertension (CTEPH): Updated Recommendations from the Cologne Consensus Conference 2018
, 2018 Chronic thromboembolic pulmonary hypertension (CTEPH) is a subgroup of pulmonary hypertension that differs from all other forms of PH in terms of its pathophysiology, patient characteristics and treatment. For implementation of the European Guidelines on Ulrich, Silvia, Klepetko, Walter, Olsson, Karen M, Gerhardt, Felix, Schmidt, Matthias, Grgic, Aleksandar, Wiedenroth, Christoph B, Guth, Stefan, Mayer, Eckhard, Schäfers, Hans-Joachim, Seyfarth, Hans-J, Krüger, Ulrich, Held, Matthias, Konstantinides, Stavros, Hinrichs, Jan B, Meyer, Bernhard C, Lankeit, Mareike, Grohé, Christian, Hoeper, Marius M, Kramm, Thorsten, Wilkens, Heinrike, Bunck, Alexander C, Lang, Irene M, Gerges, Mario +23 morecore +1 more sourceMean plasma HDL-C (mg/dL) in 3 groups of patients (CTEPH, PAH and control group).
, 2018 HDL-C in CTEPH patients is lower compared to control subjects and higher compared to PAH patients. (Mean± SD): CTEPH: (44.7 ± 15.5 mg/dL); PAH: (35.2±11.5 mg/dL); Control: (52.9 ±19.7 mg/dL); p < 0.0001 for the ANOVA test that was performed to compare ...Xiaofeng Wang (119575), Manshi Li (5309330), Nicholas Smedira (5309324), Raed A. Dweik (352149), Ghaleb Khirfan (4804248), Joseph DiDonato (5309321), Vickram Tejwani (5309327), Gustavo A. Heresi (4804251) +7 morecore +1 more sourceThe significance of CD16+ monocytes in the occurrence and development of chronic thromboembolic pulmonary hypertension: insights from single-cell RNA sequencing
Frontiers in ImmunologyBackgroundChronic thromboembolic pulmonary hypertension (CTEPH) is a serious pulmonary vascular disease characterized by residual thrombi in the pulmonary arteries and distal pulmonary microvascular remodeling.Maohe Chen, Maohe Chen, Qiuxia Wu, Qiuxia Wu, Nan Shao, Xingyue Lai, Xingyue Lai, Huo Lin, Min Chen, Min Chen, Yijing Wu, Yijing Wu, Jiafan Chen, Jiafan Chen, Qinghuang Lin, Qinghuang Lin, Jiahui Huang, Xiaoyun Chen, Xiaoyun Chen, Wei Yan, Wei Yan, Shi Chen, Hongli Li, Hongli Li, Hongli Li, Dawen Wu, Dawen Wu, Dawen Wu, Minxia Yang, Chaosheng Deng, Chaosheng Deng, Chaosheng Deng +31 moredoaj +1 more sourceCharacteristics and survival of adult Swedish PAH and CTEPH patients 2000–2014
, 2016 Objectives: The Swedish Pulmonary Arterial Hypertension Register (SPAHR) is an open continuous register, including pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) patients from 2000 and onwards.Kornhall, Björn, Wikström, Gerhard, Nisell, Magnus, Henrik Ryftenius (2831132), Göran Rådegran (2831156), Sofia Berg Blomquist (2831150), Roger Hesselstrand (213990), Monica Karlsson (2831126), Ryftenius, Henrik,, Larsen, Flemming, Barbro Kjellström (763517), Persson, Liselotte,, Björn Kornhall (2831159), Gustafsson, Carola, Selin, Maria, Nisell, Magnus,, Söderberg, Stefan, Karlsson, Monica, Rådegran, Göran,, Ryftenius, Henrik, Bengt Ullman (2831153), Wall, Kent,, Hesselstrand, Roger,, Willehadson, Maria,, Wikström, Gerhard,, Rundqvist, Bengt, Ekmehag, Björn, Rådegran, Göran, Kjellström, Barbro, Willehadson, Maria, Björn Ekmehag (700854), Liselotte Persson (2831120), Gerhard Wikström (2831129), Ullman, Bengt, Magnus Nisell (2831144), Hesselstrand, Roger, Blomquist, Sofia Berg, Maria Selin (2831141), Ekmehag, Björn,, Jansson, Kjell,, Söderberg, Stefan,, Kent Wall (2831123), Bengt Rundqvist (2831147), Carola Gustafsson (2831135), Kjellström, Barbro,, Larsen, Flemming,, Wall, Kent, Jansson, Kjell, Berg Blomquist, Sofia,, Maria Willehadson (2831138), Selin, Maria,, Karlsson, Monica,, Kornhall, Björn,, Rundqvist, Bengt,, Gustafsson, Carola,, Kjell Jansson (2340394), Ullman, Bengt,, Flemming Larsen (2498476), Persson, Liselotte +58 morecore +1 more sourceThe Occult Cascade That Leads to CTEPH
Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare, progressive form of pre-capillary pulmonary hypertension characterized by persistent, organized thromboemboli in the pulmonary vasculature, leading to vascular remodeling, elevated ...Charli Fox, Lavannya M. Panditcore +1 more sourceSerum concentrations of sRAGE in patients before and after surgery for CTEPH, iPAH and AVS.
, 2014 Box plot analysis of serum concentrations of sRAGE in patients with CTEPH (n = 20), iPAH (n = 7), AVS (n = 15) and controls (n = 28, A). Box plot analysis of sRAGE in serum of patients with CTEPH before and after PEA, in patients with iPAH before and ...Anna Megerle (625942), Tamás Szerafin (545744), Bernhard Moser (221356), Christine Bekos (547365), Peter Birner (285123), Ana-Iris Schiefer (547363), Walter Klepetko (110147), Irene Lang (625943), Michael Mildner (110113), Stefan Janik (547362), Nika Skoro-Sajer (625944), Roela Sadushi-Kolici (625945), Shahrokh Taghavi (625946), Hendrik Jan Ankersmit (110152) +13 morecore +1 more sourceA Collaborative, Interinstitutional Program to Improve the Care of Patients With Chronic Thromboembolic Pulmonary Hypertension
CHEST PulmonaryChronic thromboembolic pulmonary hypertension (CTEPH), a subcategory of pulmonary hypertension and chronic sequela of acute pulmonary embolism, is often underdiagnosed due to nonspecific symptoms. Pulmonary endarterectomy remains the optimal, potentially Bryan A. Kelly, DO, Vikas Aggarwal, MD, Prachi P. Agarwal, MD, Samuel Allen, DO, Rana Awdish, MD, Wael Berjaoui, MD, Domingo J. Franco-Palacios, MD, Reda E. Girgis, MD, Gillian Grafton, DO, Jonathan W. Haft, MD, Brandon Hooks, DO, Reem Ismail, NP, Sheila Krishnan, DO, Scott Visovatti, MD, Vallerie V. McLaughlin, MD, FACC, Victor M. Moles, MD +15 moredoaj +1 more sourcePlasma pentraxin3 (PTX3) and other biomarker's concentration in patients with CTEPH.
, 2014 A) PTX3 (ng/mL), B) BNP (pg/mL), C) CRP (mg/L), and D) H-FABP. Plasma PTX3 and BNP levels were higher in patients with CTEPH than in controls. The CTEPH patients tended to have higher plasma CRP levels than the control patients, although this difference ...Seiichiro Sakao (515628), Koichiro Tatsumi (395735), Ayako Shigeta (653977), Nobuhiro Tanabe (515632), Akira Naito (663843), Toshihiko Sugiura (653973), Keiichi Ishida (663844), Takayuki Jujo (515627) +7 morecore +1 more sourceExploring the Endothelin-1 pathway in chronic thromboembolic pulmonary hypertension microvasculopathy
Scientific ReportsTargeted vasopeptide therapies have significantly advanced the management of pulmonary arterial hypertension (PAH). However, due to insufficient preclinical evidence regarding the involvement of the endothelin-1 (ET-1) pathway in chronic thromboembolic ...Benchenouf Feriel, Cuomo Alessandra, Gorth J. Deborah, Normand Corinne, Thuillet Raphaël, Ottaviani Mina, Akamkam Ali, Menager Jean-Baptiste, Fadel Guillaume, Grynblat Julien, Ghigna Maria-Rosa, Fadel Elie, Savale Laurent, Mercier Olaf, Tu Ly, Humbert Marc, Guignabert Christophe +16 moredoaj +1 more source
